▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1421 by analyst upside · 2026-09-27
IRON
Disc Medicine, Inc.
Healthcare · Market Cap $3B · P/E 0x
ANALYST PRICE TARGET
+58.1%
implied upside to consensus target
Current Price $65.24
Consensus Target $103.17
Bull Target $128.0
Bear Target $83.0
Analysts Covering 12
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
11
Hold
0
Sell
0
52-Week Low $40.0
52-Week High $99.5
YTD Return -17.5%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-6.59
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $40.0
52-Week High $99.5
Current Price $65.24
Bear Target $83.0
Bull Target $128.0
● Now $65.24 ● Target $103.17
TRADING DATA
Avg Volume 494K
YTD Return -17.5%
Analyst Count 12
Consensus Buy
Upside to Target +58.1%
Last Updated 2026-09-27

ANALYST SUMMARY

Disc Medicine, Inc. (IRON) is currently trading at $65.24 with a Wall Street consensus price target of $103.17, implying potential upside of 58.1% over the next 12 months. 12 analysts currently cover IRON, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $128.0, while the most cautious has a target of $83.0.

IRON operates in the Healthcare sector with a market capitalisation of $3B. The stock is down 17.5% year-to-date and is currently trading near the lower end of its 52-week range of $40.0 – $99.5.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

PBH +45.5%
Prestige Consumer Healthcare Inc.
$2B · P/E 13.1x · Buy
AVAH +17.6%
Aveanna Healthcare Holdings Inc.
$3B · P/E 9.8x · Buy
ADMA +81.2%
ADMA Biologics, Inc.
$2B · P/E 13.4x · Buy
HRMY +14.8%
Harmony Biosciences Holdings, Inc.
$2B · P/E 13.4x · Buy
AUPH +8.6%
Aurinia Pharmaceuticals Inc.
$2B · P/E 7.2x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for IRON, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Wells Fargo - Reiterated
Overweight → Overweight 2026-09-16 Building track record
Wedbush reit
Outperform → Outperform 2026-09-10 Building track record
Wedbush - Reiterated
Outperform → Outperform 2026-09-02 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-08-06 31% win rate (48 calls)
Morgan Stanley - Reiterated
Overweight → Overweight 2026-06-16 Building track record
Wedbush reit
Outperform → Outperform 2026-06-10 Building track record
Morgan Stanley - Reiterated
Overweight → Overweight 2026-05-14 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-03-02 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
63
out of 100
Coverage depth
20/30
Consensus clarity
16/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →